Core Viewpoint - Jet.AI reported a decline in revenues for the second quarter of 2025, primarily due to reduced charter and jet card revenues as clients anticipated the sale of its aviation business to flyExclusive, despite an increase in software application revenue [3][4][5]. Financial Results Summary Second Quarter 2025 - Revenues were $2.2 million, down from $3.1 million in the same period last year, reflecting a decrease in Cirrus Charter and Jet Card revenue [3]. - Software App and Cirrus Charter revenue was $1.3 million compared to $1.6 million in the same period last year [4]. - Management and Other Services revenue totaled $533,000, down from $914,000 year-over-year [4]. - Jet Card and Fractional Programs revenue was $421,000, compared to $559,000 in the same period last year [5]. - Cost of revenues decreased to $2.3 million from $3.5 million, attributed to reduced charter flight activity [5]. - Gross loss was approximately $110,000, improved from a loss of $417,000 in the same period last year [6]. - Operating expenses totaled $2.4 million, down from $2.8 million, mainly due to lower general and administrative and sales and marketing expenses [6]. - Operating loss was approximately $2.5 million, compared to a loss of $3.2 million in the same period last year [7]. - As of June 30, 2025, cash and cash equivalents were approximately $8.3 million [7]. Six Months 2025 - Revenues for the six months ended June 30, 2025, were $5.7 million, down from $6.9 million in the same period last year [8]. - Software App and Cirrus Charter revenue for the six months was $3.1 million, compared to $4.0 million in the same period last year [8]. - Management and Other Services revenue totaled $1.8 million, slightly up from $1.7 million year-over-year [10]. - Jet Card and Fractional Programs revenue was $765,000, down from $1.2 million in the same period last year [10]. - Cost of revenues for the six months totaled $5.9 million, down from $7.5 million, due to decreased payments for aircraft management and operations [11]. - Gross loss for the six months was approximately $226,000, improved from $541,000 in the same period last year [12]. - Operating expenses totaled $5.4 million, down from $5.8 million, primarily due to lower general and administrative expenses [13]. - Operating loss for the six months was approximately $5.7 million, compared to a loss of $6.4 million in the same period last year [14]. Operational Highlights - The company announced a capital contribution to AIIA Sponsor Ltd., which is associated with a SPAC focusing on AI and data center opportunities [9]. - A joint venture with Consensus Core Technologies Inc. was formed to develop two hyperscale data-center campuses in Canada [9]. - The transaction with flyExclusive is on track to close by October 31, 2025 [9][16]. Company Overview - Jet.AI, founded in 2018, is transitioning to a pure-play AI data center company, leveraging expertise in data center development and AI technologies [17].

Core Insights - NextNRG reported a remarkable 166% year-over-year revenue growth for Q2 2025, reaching $19.7 million compared to $7.4 million in Q2 2024, driven by strong market demand for its integrated energy solutions [3][4][5] - The company achieved a gross profit of $1.6 million, a significant increase from $547,000 in the same quarter last year, reflecting a 189% growth in gross profit [4][5] - Despite the revenue growth, NextNRG reported a net loss of $36.1 million, which included a $30.8 million operating loss primarily due to a non-cash stock-based compensation expense of approximately $25.5 million [4][6] Financial Highlights - Revenue for Q2 2025 was $19.7 million, up from $7.4 million in Q2 2024, marking a 166% increase [4] - Gross profit increased to $1.6 million from $547,000, representing a 189% growth [4] - The operating loss was $30.8 million, compared to $2.6 million in Q2 2024, largely due to stock-based compensation [4][6] - Net loss for the quarter was $36.1 million, up from $5.6 million in the previous year [4] Strategic Developments - NextNRG is advancing its integrated energy strategy with ongoing deployments of smart microgrids and wireless EV charging programs, aiming for commercial launch [5][8] - The company is expanding its integrated platform across three revenue streams: Utility Operating System, Smart Microgrids, and Wireless EV Charging [7][12] - A strategic partnership with Hudson Sustainable Group aims to accelerate U.S. energy infrastructure buildout, providing priority access to capital for NextNRG's projects [12] - The company has extended operations into Oklahoma, marking its seventh state of operation, and has secured a long-term agreement with a major fleet operator [12] Operational Achievements - NextNRG achieved a record monthly performance in July 2025 with preliminary revenue of $8.19 million, representing a 236% year-over-year growth [12] - The company is enhancing its mobile fueling operations by integrating sustainable energy solutions and expanding its fleet of fuel delivery trucks [9][12] - A newly formed Strategic Advisory Board, chaired by Gary M. Goldfarb, will guide the company's commercial and industrial facility expansion [12]

Core Insights - NextNRG, Inc. is a leader in AI-driven energy innovation, focusing on transforming energy production, management, and delivery through its Next Utility Operating System®, smart microgrids, and wireless EV charging solutions [1][5][6] - The company will host a conference call on August 15, 2025, to discuss its financial results for Q2 2025 [1][8] Company Overview - NextNRG integrates AI and machine learning into renewable energy and next-generation energy infrastructure, including battery storage and mobile fuel delivery [4][5] - The Next Utility Operating System® aims to enhance energy management efficiency for existing utilities [5] - Smart microgrids developed by NextNRG utilize AI-driven management alongside solar power and battery storage to improve energy efficiency and grid resiliency [5] Recent Developments - NextNRG is expanding its fleet of fuel delivery trucks and has acquired Yoshi Mobility's fuel division and Shell Oil's trucks, strengthening its position in the on-demand fueling industry [6] - The company is integrating sustainable energy solutions into its mobile fueling operations and aims to assist fleet customers in transitioning to electric vehicles [6]

60 Minutes Rewind. Whether you think artificial intelligence will save the world or end it, you have Jeffrey Hinton to thank. Hinton has been called the godfather of AI.A British computer scientist whose controversial ideas help make advanced artificial intelligence possible and so change the world. Hinton believes that AI will do enormous good, but tonight he has a warning. He says that AI systems may be more intelligent than we know and there's a chance the machines could take over, which made us ask the ...

It's good to see you back in the world of technology, at least publicly. Back in the world of technology. You know, I was reading about parallel web systems, the idea that the customer is the agent and there's just a place to start.Tell us about this startup, what you're doing while you're doing it. Hey, Ed, first of all, thank you so much for having me. After leaving Twitter, one of the things I was doing was just writing a bunch of code tinkering around.I was actually building the agents a couple of years ...

Core Viewpoint - Jet.AI Inc. has made a capital contribution to AIIA Sponsor Ltd., which is sponsoring AI Infrastructure Acquisition Corp., a special purpose acquisition company aiming for an initial public offering (IPO) focused on AI and machine learning technology companies [1][2]. Group 1: Company Overview - Jet.AI Inc. is a provider of high-performance GPU infrastructure and AI cloud services, transitioning to a pure-play AI data center company [5]. - The company was founded in 2018 and is based in Las Vegas, NV, operating in two segments: Software and Aviation [5]. - Jet.AI aims to build scalable, high-performance infrastructure to meet the growing computational demands of artificial intelligence [5]. Group 2: IPO Details - AI Infrastructure Acquisition Corp. plans to conduct an IPO with a base offering size of $100 million, potentially increasing to $115 million if the underwriters fully exercise their over-allotment option [2]. - The IPO will focus on high-impact private technology companies that advance AI and machine learning capabilities, as well as those involved in next-generation data center infrastructure [2]. - Maxim Group LLC is acting as the sole book-running manager for the IPO [3].

Core Insights - V2X has appointed Stan Budraitis as Vice President of Business Development for Army Aviation Programs, bringing 35 years of experience as a U.S. Army Aviator [1][2] - Budraitis previously served as Deputy Commanding General at the U.S. Army Aviation Center of Excellence and has extensive leadership experience in Army aviation [2][3] - His operational expertise and strategic insight are expected to enhance V2X's support for Army aviation customers and expand mission-critical capabilities [3] Company Overview - V2X specializes in innovative solutions that integrate physical and digital environments, focusing on enhancing readiness, optimizing resource management, and boosting security [4] - The company operates across national security, defense, civilian, and international markets, employing approximately 16,000 professionals globally [4] - V2X leverages AI and machine learning to address complex challenges across various operational domains [4]

Core Viewpoint - Predictive Oncology reported a loss from continuing operations of approximately $2.0 million for Q2 2025, while focusing on advancing its AI-driven drug discovery and expanding its ChemoFx assay in the U.S. and Europe [1][3]. Financial Summary - The company concluded Q2 2025 with cash and cash equivalents of $506,078, down from $611,822 as of December 31, 2024 [4]. - Revenue for Q2 2025 was $2,682, a significant decrease from $67,255 in Q2 2024, primarily due to reduced sales of tumor-specific 3D models and kits [10]. - General and administrative expenses increased to $1,875,655 in Q2 2025 from $1,825,174 in Q2 2024, mainly due to higher legal fees [10]. - The company raised approximately $586,000 in gross proceeds during the quarter through private placements and its At-the-Market facility [6]. Operational Highlights - The company is preparing for an aggressive market expansion of its ChemoFx assay in the U.S. and a de novo launch in Europe, both expected in Q4 2025 [5]. - ChemoFx helps oncologists make better treatment decisions by testing multiple chemotherapies on patients' cancer cells before treatment selection [5]. - Predictive Oncology has developed two unique 3D liver toxicity models for Labcorp, which can evaluate drug metabolism and liver toxicity [5]. - The company identified three promising candidates for repurposing from abandoned drugs, specifically Afuresertib, Alisertib, and Entinosta, for colon and breast tumor indications [5]. Capital and Investment - A standby equity purchase agreement for up to $10 million was announced with YA II PN, LTD, managed by Yorkville Advisors Global, LP, providing a flexible source of capital for advancing initiatives [5].

Financial Data and Key Metrics Changes - Total revenue for Q2 2025 was $15.3 million, up from $8 million in Q2 2024, primarily due to variability in Pharma Biocatalysis customers' manufacturing schedules and clinical trial progression [14][15] - Product gross margin increased to 72% in Q2 2025 from 45% in Q2 2024, attributed to shifts in sales to more profitable products [15][17] - The net loss for Q2 2025 was $13.3 million, compared to $22.8 million in Q2 2024, indicating improved financial performance [17] Business Line Data and Key Metrics Changes - The Pharma Biocatalysis business saw increased orders for enzymes supporting late-phase and commercialized APIs, contributing to strong Q2 revenue [6][14] - The Ecosynthesis platform is experiencing strong customer engagement, with over 30 ongoing customer engagements, indicating growing demand [5][21] Market Data and Key Metrics Changes - The demand for the Ecosynthesis platform is expected to exceed supply, prompting the company to explore options to expand capacity [5][12] - The ligation process is becoming the new standard in siRNA manufacturing, with the company focusing on acquiring new ligase customers [9][10] Company Strategy and Development Direction - The company aims to achieve cash flow breakeven by 2026 while exploring ways to maximize stockholder value through the Ecosynthesis platform [4][5] - A strategy is in place to secure early-phase products on the ECO platform, which could lead to significant returns as these products mature into commercial drugs [5][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the trajectory towards profitability and highlighted the importance of managing expenses while capitalizing on the strong cash position [17] - The company anticipates continued revenue lumpiness in the near term due to the unpredictability of the heritage business, but expects growth from the Ecosynthesis platform in the coming years [15][30] Other Important Information - The company ended the quarter with $66.3 million in cash and equivalents, sufficient to fund operations through 2027 [18] - Management is focused on establishing a GMP facility to improve the scale-up process and service small to medium-sized drug innovators [12][34] Q&A Session Summary Question: Can you provide an update on the pipeline and customer discussions? - The company has over 30 discussions ongoing, potentially growing into the 40s, with a mix of CDMOs and biopharma companies [21][22] Question: What is the status of process development projects in the Eco Innovation Lab? - The company is excited about recruiting early-phase projects and is considering setting up a second Eco Lab to increase capacity [27][28] Question: How does the company plan to expand bandwidth for the ECO platform? - The focus is on filling existing capacity and exploring partnerships while ensuring a credible path to GMP material [33][35] Question: What is the company's IP position around Ecosynthesis? - The company has a strong IP portfolio and emphasizes the importance of trade secrets and know-how in maintaining a competitive edge [37][38] Question: How should investors think about revenue collection pace? - The company aims to lock in a large number of early-stage projects, which could lead to significant future revenues as these assets mature [42][46] Question: What are the options for funding scaling to GMP? - The company is not considering selling its biocatalysis business, as it is profitable and reduces cash needs, while also planning incremental scaling [68][69]

Core Insights - Tevogen Bio Holdings Inc. is expanding its collaboration with Microsoft and Databricks to develop the beta version of its PredicTcell model, focusing on oncology [1][7] - The initiative aims to enhance the accuracy of the PredicTcell model by curating a dataset that combines oncology and virology data [2][7] - The development is supported by a recently published international patent application outlining novel machine learning systems for predicting immunologically active peptides, crucial for targeted therapies [3] Company Developments - Tevogen.AI is leveraging the Databricks Data Intelligence Platform to improve its foundational AI model, which is particularly impactful in drug discovery for oncology [2][4] - The company plans to explore external market opportunities as a potential revenue source while enhancing analytics and visualization tools for its internal R&D teams [7] - The collaboration with Microsoft and Databricks has been highlighted as a significant advantage in building the alpha version of the AI model [4]